Skip to main content
Clinical Trials/NCT07724236
NCT07724236CompletedNot Applicable

A Retrospective Study on the Treatment of Stage ll Kümmell's Disease With Cement-Augmented Short-Segment Internal Fixation

The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine1 site in 1 country60 target enrollmentStarted: November 30, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
Postoperative Anterior Height of Adjacent Healthy Intervertebral Discs

Study Overview

Brief Summary

This retrospective study compares the clinical and radiographic outcomes of percutaneous vertebroplasty (PVP) versus cement-augmented short-segment percutaneous pedicle screw fixation for the treatment of single-level stage II Kümmell's Disease (KD). A total of 60 patients who failed conservative treatment for at least 6 weeks and completed a minimum of 3 months of follow-up were included. The primary outcomes are Visual Analogue Scale (VAS) for low back and lower limb pain, and Cobb's angle correction and maintenance rates. Secondary outcomes include Oswestry Disability Index (ODI), vertebral anterior height maintenance rate, implant-related complications, and reoperation rate. This study aims to provide evidence for optimizing treatment strategies in stage II KD.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Retrospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with imaging findings consistent with stage II KD and corresponding clinical symptoms and signs;
  • All cases involve single-level lesions;
  • Individuals who have shown no improvement or experienced symptom progression after more than 6weeks of conservative treatment;
  • Patients with complete clinical and imaging data before and after surgery;
  • Those who were followed up for at least 3 months postoperatively.

Exclusion Criteria

  • Patients with multilevel lumbar spondylolisthesis;
  • Individuals with a history of previous lumbar spine surgery;
  • Patients with spinal infection;
  • Individuals with uncontrolled hypertension;
  • Patients with uncontrolled diabetes mellitus;
  • Those with severe impairment of cardiac, pulmonary, liver, or kidney function;
  • Patients with gonadal diseases, adrenal diseases, parathyroid diseases, thyroid diseases, and pituitary disorders;
  • Individuals with a history of immunodeficiency diseases (such as HIV), cancer or malignant tumors, autoimmune diseases, severe cardiovascular or cerebrovascular diseases, or other conditions that may significantly reduce life expectancy;
  • Patients who have participated in any drug clinical trial within the last six months before screening;
  • Individuals with a clear history of mental illness or cognitive impairment who are unable to cooperate with follow-up and efficacy assessments;
  • Patients deemed unsuitable for participation in this study by the researchers.

Outcomes

Primary Outcomes

Postoperative Anterior Height of Adjacent Healthy Intervertebral Discs

Time Frame: At discharge

Vertebral Anterior Height Maintenance Rate

Time Frame: Baseline (within 7 days preoperatively) and at the 3-month postoperative follow-up visit

Postoperative Incidence of Complications Related to Internal Fixation

Time Frame: From surgery through the 3-month postoperative follow-up visit

Preoperative Anterior Height of Intervertebral Disc

Time Frame: Baseline (within 7 days preoperatively)

Postoperative Anterior Height of Intervertebral Disc

Time Frame: At discharge

Preoperative Anterior Height of Ajacent Healthy Intervertebral Discs

Time Frame: Baseline (within 7 days preoperatively)

Secondary Outcomes

  • Postoperative Lumbar Pain Visual Analogue Scale Score(At the 3-month postoperative follow-up visit)
  • Preoperative Lumbar Pain Visual Analog Scale Score(Baseline (within 7 days preoperatively))
  • Postoperative Lower Extremity Pain Visual Analog Scale score(At the 3-month postoperative follow-up visit)
  • Preoperative Lower Extremity Pain Visual Analog Scale Score(Baseline (within 7 days preoperatively))
  • Preoperative Oswestry Disability Index(Baseline (within 7 days preoperatively))
  • Postoperative Oswestry Disability Index(At the 3-month postoperative follow-up visit.)
  • Preoperative Cobb's angle(Baseline (within 7 days preoperatively))
  • Postoperative Cobb's angle(At the 3-month postoperative follow-up visit)
  • Reoperation rate(Up to 3 months after surgery)

Investigators

Sponsor
The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Dongping Wang

Resident Physician

The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine

Study Sites (1)

Loading locations...

Similar Trials